Lobbying client

HEALIANCE PHARMACEUTICALS

medical innovation

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
22
Filed by
2
Reported in-house
—
Reported by firms
$470,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2011 to 2014

Filings

22 filings, newest first.
Filing Filed by Amount
2nd Quarter - Amendment
2nd Quarter 2014
DELAHUNT GROUP, LLC $50,000 reported
3rd Quarter - Termination
3rd Quarter 2014
DELAHUNT GROUP, LLC $20,000 reported
2nd Quarter - Reportreplaced
2nd Quarter 2014
DELAHUNT GROUP, LLC $50,000 reported
1st Quarter - Report
1st Quarter 2014
DELAHUNT GROUP, LLC $45,000 reported
1st Quarter - Report (No Activity)
1st Quarter 2014
GEPHARDT GROUP GOVERNMENT AFFAIRS — reported
4th Quarter - Report (No Activity)
4th Quarter 2013
GEPHARDT GROUP GOVERNMENT AFFAIRS — reported
4th Quarter - Report
4th Quarter 2013
DELAHUNT GROUP, LLC $45,000 reported
3rd Quarter - Report (No Activity)
3rd Quarter 2013
GEPHARDT GROUP GOVERNMENT AFFAIRS — reported
3rd Quarter - Report
3rd Quarter 2013
DELAHUNT GROUP, LLC $45,000 reported
2nd Quarter - Report (No Activity)
2nd Quarter 2013
GEPHARDT GROUP GOVERNMENT AFFAIRS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
DELAHUNT GROUP, LLC 6 $250,000
GEPHARDT GROUP GOVERNMENT AFFAIRS 12 $220,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Foreign Relations FOR 13
Pharmacy PHA 12
Health Issues HCR 12

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.